ReviewCancer drug resistance (Alhambra, Calif.)2025

New advances in understanding the mechanisms and treatment challenges of ALK-targeted therapy resistance in lung cancer.

Mengle Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.